D. E. Shaw Adds $67M in Avantor, Inc. ($AVTR)

Key Points

  • D. E. Shaw changed its Avantor, Inc. ($AVTR) stake by 110.9% last quarter, boosting to 13,110,674 shares worth $126.65 million.
  • Wall Street's consensus rating on $AVTR is Hold and an average price target of $9.67.
  • $AVTR last traded around $9.66.

D. E. Shaw increased its position in Avantor, Inc. ($AVTR) by 110.9% during the most recent quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 13,110,674 shares of Avantor, Inc. after buying 6,894,751 shares during the quarter. D. E. Shaw's holdings in Avantor, Inc. were worth $126.65 million as of its most recent filing.

Avantor, Inc. ($AVTR) Stock

Last price$9.66
Market cap$6.41B
Forward P/E11.04
Beta0.96
52-week low$7.26
52-week high$15.93
50-day MA$8.38
200-day MA$10.59
Current ratio1.76
Quick ratio1.01
Debt-to-equity0.68

Avantor, Inc. Earnings

EPS (ttm)$-0.81
Revenue (ttm)$6.55B
Revenue growth0.0%
Net margin-8.4%
Return on equity-9.4%
Next earningsApr 29, 2026

Analysts Set New Price Targets

ConsensusHold
Average target$9.67
High target$19.00
Low target$7.00
Analysts covering15

About Avantor, Inc.

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, peristaltic pumps, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, compound management, cleanroom control, monitoring, maintenance, and sanitization services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.

ExchangeNYSE
SectorHealthcare
IndustryMedical Instruments & Supplies
HeadquartersRadnor, PA
CEOMr. Emmanuel Ligner
Employees13,500

See Also

This instant news alert was generated by automated narrative technology and financial data from Opentrades and public regulatory filings. It is for informational purposes only and is not financial advice.